Alvogen Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Alvogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10560
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alvogen Inc (Alvogen) is a pharmaceutical company that develops, manufactures and markets generic pharmaceuticals, brand and over the counter (OTC) products. The company offers generic medications in the therapeutic areas of oncology, cardiology, respiratory, neurology and gastroenterology. It also provides services such as product development, contract manufacturing and research services. Alvogen’s OTC categories include food supplements, OTC medicines, cosmetics and medical devices. It offers products in various dosage forms of solid oral dosage, modified release tablets, soft gelatin capsules, creams, ointments, transdermals and injectables. The company operates through its manufacturing and development facilities located in the US, Taiwan, South Korea and Romania. Alvogen is headquartered in Pine Brook, New Jersey, the US.

Alvogen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alvogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alvogen Inc, Medical Devices Deals, 2012 to YTD 2018 10
Alvogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Alvogen Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Lotus Pharma Acquires Osteoporosis from Novartis 13
Alvogen Acquires Five Hormonal Products from Bayer Pharma 14
Alvogen to Acquire Four Pharma Products from Pfizer 15
Private Equity 16
CVC Capital, Temasek and Vatera Healthcare Partners Acquire Majority Stake in Alvogen 16
Pamplona Capital Management Acquires Majority Stake In Alvogen 18
Partnerships 19
Alvogen Enters into Distribution Agreement with Theramex 19
Lotus Pharma, Tzu Chi Hospital and EF Biotech to Enter into Agreement 20
Alvogen Enters into Marketing Agreement with AstraZeneca 21
Probi Enters Into Distribution Agreement With Alvogen 22
Licensing Agreements 23
Alvogen Enters into Licensing Agreement with Prestige BioPharma 23
Alvogen Malta Operations Enters into Licensing Agreement with Pfenex 24
Luye Pharma Enters into Licensing Agreement with Lotus Pharma 25
Asset Transactions 26
Lotus Pharma Plans to Sell Product Rights 26
Acquisition 27
CVC Capital, Temasek and Vatera Healthcare May Sell Alvogen for up to USD4 Billion 27
Alvogen Acquires Omega Bittner from Perrigo for USD15 Million 28
Alvogen Acquires County Line Pharma 29
Alvogen Acquires Dream Pharma for USD184 Million 30
Alvogen To Acquire 67% Stake In Lotus Pharma For US$205 Million 31
Alvogen Completes Acquisition Of LaborMed Pharma, Maker Of Generic Drugs 32
Alvogen Completes Acquisition Of 67% Stake In KunWha Pharma For US$68 Million 33
Alvogen Inc – Key Competitors 34
Alvogen Inc – Key Employees 35
Alvogen Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 38
Corporate Communications 38
Jan 16, 2018: Lotus Enters Management Team Integration With Alvogen – Petar Vazharov Steps Up As Lotus General Manager 38
Legal and Regulatory 39
Aug 10, 2018: Drugmaker sues, asks court to block use of its product in Nevada execution on Wednesday 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Alvogen Inc, Pharmaceuticals & Healthcare, Key Facts 2
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alvogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alvogen Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Alvogen Inc, Medical Devices Deals, 2012 to YTD 2018 10
Alvogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Lotus Pharma Acquires Osteoporosis from Novartis 13
Alvogen Acquires Five Hormonal Products from Bayer Pharma 14
Alvogen to Acquire Four Pharma Products from Pfizer 15
CVC Capital, Temasek and Vatera Healthcare Partners Acquire Majority Stake in Alvogen 16
Pamplona Capital Management Acquires Majority Stake In Alvogen 18
Alvogen Enters into Distribution Agreement with Theramex 19
Lotus Pharma, Tzu Chi Hospital and EF Biotech to Enter into Agreement 20
Alvogen Enters into Marketing Agreement with AstraZeneca 21
Probi Enters Into Distribution Agreement With Alvogen 22
Alvogen Enters into Licensing Agreement with Prestige BioPharma 23
Alvogen Malta Operations Enters into Licensing Agreement with Pfenex 24
Luye Pharma Enters into Licensing Agreement with Lotus Pharma 25
Lotus Pharma Plans to Sell Product Rights 26
CVC Capital, Temasek and Vatera Healthcare May Sell Alvogen for up to USD4 Billion 27
Alvogen Acquires Omega Bittner from Perrigo for USD15 Million 28
Alvogen Acquires County Line Pharma 29
Alvogen Acquires Dream Pharma for USD184 Million 30
Alvogen To Acquire 67% Stake In Lotus Pharma For US$205 Million 31
Alvogen Completes Acquisition Of LaborMed Pharma, Maker Of Generic Drugs 32
Alvogen Completes Acquisition Of 67% Stake In KunWha Pharma For US$68 Million 33
Alvogen Inc, Key Competitors 34
Alvogen Inc, Key Employees 35
Alvogen Inc, Subsidiaries 36

List of Figures
Alvogen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alvogen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alvogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alvogen Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Alvogen Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KPC Pharmaceuticals Inc (600422):製薬・医療:M&Aディール及び事業提携情報
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and special botanical drugs. It also offers drugs suc …
  • Jutal Offshore Oil Services Ltd (3303):石油・ガス:M&Aディール及び事業提携情報
    Summary Jutal Offshore Oil Services Ltd (Jutal), a subsidiary of Cheung Hing Investments Ltd is an oil and gas company that offers oil and gas equipment and offshore engineering and technical supporting services. The company's products include natural gas processing systems, subsea equipment, produc …
  • Guangzhou Wondfo Biotech Co Ltd (300482):医療機器:M&Aディール及び事業提携情報
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that develops, manufactures and supplies rapid diagnostic reagents and related equipment. Its products include rapid quantitative test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo also of …
  • American Family Insurance Group:企業の戦略・SWOT・財務情報
    American Family Insurance Group - Strategy, SWOT and Corporate Finance Report Summary American Family Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • National Research Corp (NRCIB):企業の財務・戦略的SWOT分析
    Summary National Research Corp (NRC) is a healthcare organization that provides market insight solutions. The company’s solutions include experience collection, market insights, transparency of experience data and governance. It offers market insights solutions that allow the tracking of awareness, …
  • HIL Limited (HIL):企業の財務・戦略的SWOT分析
    HIL Limited (HIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Daiwa Can Co., Ltd.:企業の戦略・SWOT・財務情報
    Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daiwa Can Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Menarini Asia-Pacific Holdings Pte Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary A. Menarini Asia-Pacific Holdings Pte Ltd (A. Menarini Asia-Pacific), formerly Invida Group Pte Ltd, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a biopharmaceutical company that develops consumer health care products. The company operates through its divisions includin …
  • Metagenics Inc:企業の戦略的SWOT分析
    Metagenics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Senvion SA-エネルギー分野:企業M&A・提携分析
    Summary Senvion S.A. (Senvion), formerly Senvion S.a.r.l, is a renewable energy company that develops, produces and distributes onshore and offshore wind turbines and towers. It also offers project specific solutions such as turnkey , foundation construction, transport and installation, and service …
  • Waterstone Financial Inc (WSBF):企業の財務・戦略的SWOT分析
    Waterstone Financial Inc (WSBF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Okinawa Cellular Telephone Company (9436):企業の財務・戦略的SWOT分析
    Okinawa Cellular Telephone Company (9436) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • PG&E Corp (PCG):企業の財務・戦略的SWOT分析
    PG&E Corp (PCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Daiichi Sankyo Co Ltd (4568):企業の財務・戦略的SWOT分析
    Daiichi Sankyo Co Ltd (4568) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Etablissements Maurel & Prom SA Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Etablissements Maurel & Prom SA Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Etablissements Maurel & Prom SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comp …
  • WAVE Life Sciences Ltd (WVE):企業の財務・戦略的SWOT分析
    Summary Wave Life Sciences Ltd (Wave Life Sciences) formerly WAVE Life Sciences Pte Ltd, discovers, develops and commercializes medicines for genetic diseases. The company's pipeline comprises an mRNA transcript candidates: WVE-120101 and WVE-120102 for Huntington's disease; ATXN3 gene candidate for …
  • TVS Motor Co Ltd:戦略・SWOT・企業財務分析
    TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary TVS Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • SciBase AB (SCIB):医療機器:M&Aディール及び事業提携情報
    Summary SciBase AB (SciBase) is a medical technology company that offers non-invasive detection and monitoring of skin tissue alterations. The company develops point of care device for the accurate detection of malignant melanoma. It offers electrical impedance spectroscopy which uses the varying el …
  • Advent Capital (Holdings) Ltd:企業の戦略・SWOT・財務情報
    Advent Capital (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Advent Capital (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Liberty Mutual Holding Company Inc.:企業の戦略・SWOT・財務情報
    Liberty Mutual Holding Company Inc. - Strategy, SWOT and Corporate Finance Report Summary Liberty Mutual Holding Company Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆